Biography

Dr. Moawad completed his doctoral thesis in the laboratory of Dr. Felix Althaus; University of Zurich- Switzerland (2003), in the fields of signal transduction, apoptosis and tumor suppression pathways under genotoxic stresses. His research revealed the involvement of Poly (ADP-ribose) Polymerase-1 (PARP-1) in the stability of tumor suppressor p53 protein upon DNA damage. Such research work exposed Dr. Moawad to multidisciplinary experiences in fields of cellular and molecular biology, biochemistry and bioinformatics.

After getting his doctoral thesis, he was enrolled in a running project towards production of genetically-engineered prototype vaccine against Corynebacterium pseudotuberculosis by targeting its exotoxin phospholipase D (PLD) protein. Recently, Dr. Moawad shared the direct submission of Corynebacterium pseudotuberculosis full genome sequence into the database of NCBI Gene Bank in cooperation with a large team of research scientists from different Brazilian Federal Universities.

Dr. Moawad was promoted as an Associate Professor at department of Veterinary Toxicology and Forensic Medicine for his publications in the fields of animal species identification and genetic forensics using molecular biology techniques. Nowadays, he is focusing intensively on the safety assurance and toxicity testing of Engineered Nano-Particles (ENPs) on mammals and environment using OECD International guidelines

Dr. Moawad holds a bachelor in Veterinary Medicine (1993) and a master degree in toxicology (1997) from the Veterinary College, Cairo University, Egypt. His research interests are biotoxins, genetic toxicology, Nanotoxicity of ENPs and genetic forensics.